TY - JOUR T1 - Precision Multiparameter Tracking of Inflammation on Timescales of Hours to Years Using Serial Dried Blood Spots JF - medRxiv DO - 10.1101/2019.12.09.19014233 SP - 2019.12.09.19014233 AU - N. Leigh Anderson AU - Morteza Razavi AU - Matthew E. Pope AU - Richard Yip AU - L. C. Cameron AU - Adriana Bassini-Cameron AU - Terry W. Pearson Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/12/14/2019.12.09.19014233.abstract N2 - High-frequency longitudinal tracking of inflammation using dried blood microsamples provides a new window for personalized monitoring of infections, chronic inflammatory disease, and clinical trials of anti-inflammatory drugs. Using 1,662 dried blood spot samples collected by 16 subjects over periods of weeks to years, we studied the behavior of 12 acute phase response (APR) and related proteins in inflammation events correlated with infection, vaccination, surgery, intense exercise and Crohn’s disease. Proteins were measured using SISCAPA mass spectrometry and normalized to constant plasma volume using low-variance proteins, generating high precision within-person biomarker trajectories with well-characterized personal baselines. The results shed new light on the dynamic regulation of APR proteins and offer a new approach to visualization of multidimensional inflammation trajectories.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by SISCAPA Assay Technologies, Inc. Authors LCC and ABC acknowledge support from the Brazilian Olimpic Comitte (BOC), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Financiadora de Estudos e Projetos (FINEP), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Merck-Sigma-Aldrich; Universidade Federal do Estado do Rio de Janeiro (UNIRIO) and Waters Corporation. No writing assistance was utilized in the production of this manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available to collaborators by agreement with SISCAPA Assay Technologies.A1AGα-1-acid glycoproteinAlbAlbuminC3Complement C3CRPC- reactive proteinFibGFibrinogen γ chainHpHaptoglobinHxHemopexinIgMImmunoglobulin MLPSBPLPS-binding proteinMBLMannose binding lectinMPOMyeloperoxidaseSAASerum amyloid AAPRacute phase responseSISCAPAStable Isotope Standards and Capture by Anti-Peptide AntibodiesPARpeak area ratioMRM-MSmultiple reaction monitoring MS ER -